These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4614295)

  • 21. [Characteristics of metabolic disorders in chronic destructive pulmonary tuberculosis after treatment with rifampicin and ethambutol].
    Kharakter ZhZ; Pavlenko AV
    Probl Tuberk; 1976 Nov; (11):44-9. PubMed ID: 1019127
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 23. [First experiences in the treatment of pulmonary tuberculosis with myambutol at the Institute for Tuberculosis of the SR Serbia].
    Grujić M; Praso R; Milovanović M; Budisavljević M; Djurić O; Laban M; Macanović J; Malenić S; Martinis U; Nikolić A; Popović J; Putnik D; Stosic A; Vanić D; Zegarac D
    Plucne Bolesti Tuberk; 1969; 21(2):212-7. PubMed ID: 5198536
    [No Abstract]   [Full Text] [Related]  

  • 24. Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1969; 69():43-53. PubMed ID: 4906373
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of patients with infiltrative tuberculosis of the lungs with tuberculin in combination with ethambutol and rifadin].
    Sattar IKh
    Probl Tuberk; 1984 May; (5):65-6. PubMed ID: 6377303
    [No Abstract]   [Full Text] [Related]  

  • 26. Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
    Meissner G
    Acta Tuberc Pneumol Belg; 1969; 60(3):554-6. PubMed ID: 4906103
    [No Abstract]   [Full Text] [Related]  

  • 27. Five years of clinical experience with rifampicin.
    Gyselen A; Cosemans J; Lacquet LM; Vandenbergh E; Verbist L
    Acta Tuberc Pneumol Belg; 1971; 62(4):289-307. PubMed ID: 4948635
    [No Abstract]   [Full Text] [Related]  

  • 28. Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis.
    Kraan JK; Mulder RJ; van Dijk B
    Acta Tuberc Pneumol Belg; 1969; 60(3):557-62. PubMed ID: 4906104
    [No Abstract]   [Full Text] [Related]  

  • 29. A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis.
    Gyselen A; Verbist L; Cosemans J; Lacquet LM; Prignot J; Simon-Pouthier F; Debrabandere R; Devriendt J
    Acta Tuberc Pneumol Belg; 1969; 60(3):563-76. PubMed ID: 4906105
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 31. [Healing processes in experimental tuberculosis treated with rifampicin and ethambutol].
    Uvarova OA; Kozulitsina TI; Korotaev GA
    Probl Tuberk; 1971; 49(12):56-60. PubMed ID: 5159691
    [No Abstract]   [Full Text] [Related]  

  • 32. [Intermittent method of using rifadin in chronic destructive pulmonary tuberculosis].
    Rudoĭ NM; Eĭsaev BA
    Klin Med (Mosk); 1974 Dec; 52(12):34-8. PubMed ID: 4444242
    [No Abstract]   [Full Text] [Related]  

  • 33. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C; Timoşca S; Petreanu V; Petreanu C; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effectiveness of rifampin and ethambutol in the treatment of pulmonary tuberculosis].
    Gol'dshteĭn VD; Prokhorov EP
    Probl Tuberk; 1973; 51(12):36-40. PubMed ID: 4782101
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of rifampin and ethambutol for the treatment of pulmonary tuberculosis].
    Shukiurov ShZ
    Probl Tuberk; 1973; 51(12):40-3. PubMed ID: 4782102
    [No Abstract]   [Full Text] [Related]  

  • 37. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 38. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pecularities of the healing process under the effect of rifampicin and ethambutol (experimental study)].
    Uvarova OA; Kozulicyna TI; Korotajev GA
    G Ital Chemioter; 1972; 19(2):11-5. PubMed ID: 4666005
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.